Growth Metrics

Purple Biotech (PPBT) Change in Working Capital (2017 - 2019)

Purple Biotech has reported Change in Working Capital over the past 3 years, most recently at $699000.0 for Q2 2019.

  • Quarterly Change in Working Capital fell 38.63% to $699000.0 in Q2 2019 from the year-ago period, while the trailing twelve-month figure was $699000.0 through Jun 2019, down 38.63% year-over-year, with the annual reading at $808000.0 for FY2025, 118.65% up from the prior year.
  • Change in Working Capital was $699000.0 for Q2 2019 at Purple Biotech, down from $1.1 million in the prior quarter.
  • Over five years, Change in Working Capital peaked at $1.1 million in Q2 2018 and troughed at -$907000.0 in Q2 2017.
  • The 3-year median for Change in Working Capital is $699000.0 (2019), against an average of $310333.3.
  • Year-over-year, Change in Working Capital surged 225.58% in 2018 and then crashed 38.63% in 2019.
  • A 3-year view of Change in Working Capital shows it stood at -$907000.0 in 2017, then surged by 225.58% to $1.1 million in 2018, then crashed by 38.63% to $699000.0 in 2019.
  • Per Business Quant, the three most recent readings for PPBT's Change in Working Capital are $699000.0 (Q2 2019), $1.1 million (Q2 2018), and -$907000.0 (Q2 2017).